person · Reporting owner
Oberton Karleen Marie
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMETEK INC/AME · Entity 3025 | Director | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMETEK INC/
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,640 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 950 · Balance 5,640 F1: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HOLOGIC INC
Report date April 07, 2026 · Filed April 09, 2026
Section 16 reporting ended · disclosed 2026-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 1
1 source rowRow 1 · 2026-04-07 · Disposition to issuer · Disposed 150,735 · Balance 0 F1: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan. F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.61 · Expires 2029-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-07 · Disposition to issuer · Disposed 30,774 · Balance 0 F4: For Footnote (4), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.35 · Expires 2030-11-09 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-07 · Disposition to issuer · Disposed 23,767 · Balance 0 F4: For Footnote (4), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.13 · Expires 2031-11-08 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-07 · Disposition to issuer · Disposed 23,775 · Balance 0 F4: For Footnote (4), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.35 · Expires 2032-11-07 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-07 · Disposition to issuer · Disposed 21,743 · Balance 0 F4: For Footnote (4), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.94 · Expires 2033-11-14 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-07 · Disposition to issuer · Disposed 25,070 · Balance 0 F4: For Footnote (4), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $79.39 · Expires 2034-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-04-07 · Disposition to issuer · Disposed 28,047 · Balance 0 F4: For Footnote (4), see Remarks below. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 42,707 |
Reported balance
After 2026-04-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-04-07 · Grant · Acquired 42,707 · Balance 42,707 F5: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F6: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-04-07 · Disposition to issuer · Disposed 42,707 · Balance 0 F5: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F6: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan.
F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration").
F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F4: For Footnote (4), see Remarks below.
F5: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock.
F6: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerPerformance Stock Units · Derivative | 42,707 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · derivative · entry 9 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,707 shares Expires not disclosed F5 · derivative.exercise_price: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F6 · price: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. F6 · derivative.exercise_date: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. F6 · derivative.expiration_date: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantPerformance Stock Units · Derivative | 42,707 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · derivative · entry 8 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,707 Underlying: Common Stock · 42,707 shares Expires not disclosed F5 · derivative.exercise_price: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F6 · price: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. F6 · derivative.exercise_date: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. F6 · derivative.expiration_date: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 28,047 | Not disclosed Strike: $79.39 | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · derivative · entry 7 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,047 shares Expires 2034-11-11 F4 · price: For Footnote (4), see Remarks below. F4 · derivative.exercise_date: For Footnote (4), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 25,070 | Not disclosed Strike: $71.94 | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · derivative · entry 6 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,070 shares Expires 2033-11-14 F4 · price: For Footnote (4), see Remarks below. F4 · derivative.exercise_date: For Footnote (4), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 21,743 | Not disclosed Strike: $74.35 | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · derivative · entry 5 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,743 shares Expires 2032-11-07 F4 · price: For Footnote (4), see Remarks below. F4 · derivative.exercise_date: For Footnote (4), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 23,775 | Not disclosed Strike: $71.13 | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · derivative · entry 4 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,775 shares Expires 2031-11-08 F4 · price: For Footnote (4), see Remarks below. F4 · derivative.exercise_date: For Footnote (4), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 23,767 | Not disclosed Strike: $68.35 | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · derivative · entry 3 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,767 shares Expires 2030-11-09 F4 · price: For Footnote (4), see Remarks below. F4 · derivative.exercise_date: For Footnote (4), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerNon-qualified Stock Option (Right to Buy) · Derivative | 30,774 | Not disclosed Strike: $45.61 | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · derivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,774 shares Expires 2029-11-11 F4 · price: For Footnote (4), see Remarks below. F4 · derivative.exercise_date: For Footnote (4), see Remarks below. Read SEC document |
| April 07, 2026 Filed Apr 9, 2026 21:32 UTC | HOLOGIC INC HOLX · Entity 12463 | Disposition to issuerCommon Stock | 150,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-26-000087 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan. F2 · price: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F3 · price: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. Read SEC document |
| March 18, 2026 Filed Mar 18, 2026 22:02 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 950 | $212.77 | $202,131.50 |
DisclosureSEC source: 0001037868-26-000085 · wk-form4_1773871318.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,640 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 17:56 UTC | AMETEK INC/ AME · Entity 3025 | GiftCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001037868-25-000110 · wk-form4_1767203795.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,690 Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 21:25 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 1,333 | $74.15 | $98,841.95 |
DisclosureSEC source: 0000859737-25-000080 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,735 F1 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 21:24 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 1,449 | $74.60 | $108,095.40 |
DisclosureSEC source: 0000859737-25-000054 · form4.xml · nonDerivative · entry 3 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,068 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 21:24 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 43,741 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-25-000054 · form4.xml · nonDerivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,517 F3 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 10, 2025. F4 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:24 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 9,427 | $74.10 | $698,540.70 |
DisclosureSEC source: 0000859737-25-000054 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,776 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 21:45 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 17,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000859737-25-000042 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,203 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 21:07 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,030 | $176.08 | $181,362.40 |
DisclosureSEC source: 0001127602-25-009820 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,940 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 1,332 | $77.54 | $103,283.28 |
DisclosureSEC source: 0001127602-24-027516 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,108 F1 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 01:40 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 28,047 | $0.00 Strike: $79.39 | $0.00 |
DisclosureSEC source: 0001127602-24-027123 · form4.xml · derivative · entry 4 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,047 Underlying: Common Stock · 28,047 shares Expires 2034-11-11 F5 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 11, 2024. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 01:40 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 9,447 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-027123 · form4.xml · nonDerivative · entry 3 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,440 F3 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 11, 2024. F4 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 01:40 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 12,598 | $78.76 | $992,218.48 |
DisclosureSEC source: 0001127602-24-027123 · form4.xml · nonDerivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,993 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 07, 2024 Filed Nov 13, 2024 01:40 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 1,161 | $79.29 | $92,055.69 |
DisclosureSEC source: 0001127602-24-027123 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,591 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 05, 2024 Filed Nov 7, 2024 21:20 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 23,710 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026725 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,752 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 20:15 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 6,725 | $0.00 Strike: $40.85 | $0.00 |
DisclosureSEC source: 0001127602-24-023300 · form4.xml · derivative · entry 5 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,725 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, December 1, 2017. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 20:15 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 26,080 | $0.00 Strike: $40.97 | $0.00 |
DisclosureSEC source: 0001127602-24-023300 · form4.xml · derivative · entry 4 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,080 shares Expires 2028-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, November 12, 2018. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 20:15 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 52,679 | $80.56 | $4,243,662.20 |
DisclosureSEC source: 0001127602-24-023300 · form4.xml · nonDerivative · entry 3 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,042 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted on May 30, 2024. F3 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $80.32 to $80.84 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 20:15 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 6,725 | $40.85 | $274,716.25 |
DisclosureSEC source: 0001127602-24-023300 · form4.xml · nonDerivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted on May 30, 2024. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 20:15 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 26,080 | $40.97 | $1,068,497.60 |
DisclosureSEC source: 0001127602-24-023300 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted on May 30, 2024. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 20:14 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,030 | $181.93 | $187,387.90 |
DisclosureSEC source: 0001127602-24-010778 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,910 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| January 29, 2024 Filed Jan 30, 2024 21:08 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 14,940 | $75.00 | $1,120,500.00 |
DisclosureSEC source: 0001127602-24-002604 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,916 F1 · shares: Transaction pursuant to an existing Rule 10b5-1 trading plan adopted on September 9, 2023. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 25,070 | $0.00 Strike: $71.94 | $0.00 |
DisclosureSEC source: 0001127602-23-027625 · form4.xml · derivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,070 Underlying: Common Stock · 25,070 shares Expires 2033-11-14 F4 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 14, 2023. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 8,687 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-027625 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,856 F1 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 14, 2023. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 22:07 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 10,899 | $67.20 | $732,412.80 |
DisclosureSEC source: 0001127602-23-027275 · form4.xml · nonDerivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,169 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 22:07 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 688 | $68.27 | $46,969.76 |
DisclosureSEC source: 0001127602-23-027275 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,068 F1 · shares: Shares withheld for tax obligations in connection with the settlement of performance stock units/restricted stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 07, 2023 Filed Nov 8, 2023 22:11 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 740 | $68.37 | $50,593.80 |
DisclosureSEC source: 0001127602-23-027044 · form4.xml · nonDerivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,756 F4 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 22:11 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 4,633 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-027044 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,496 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 12:54 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,210 | $138.46 | $167,536.60 |
DisclosureSEC source: 0001127602-23-011084 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,880 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:49 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 15,145 | $75.93 | $1,149,959.85 |
DisclosureSEC source: 0001127602-22-025508 · form4.xml · nonDerivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,863 F1 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units/performance stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 21:49 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 680 | $72.11 | $49,034.80 |
DisclosureSEC source: 0001127602-22-025508 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,008 F1 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units/performance stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 22:07 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 688 | $73.71 | $50,712.48 |
DisclosureSEC source: 0001127602-22-025213 · form4.xml · nonDerivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,688 F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 22:07 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 7,565 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-025213 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,376 F1 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 7, 2022. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:07 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 21,743 | $0.00 Strike: $74.35 | $0.00 |
DisclosureSEC source: 0001127602-22-025213 · form4.xml · derivative · entry 3 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,743 Underlying: Common Stock · 21,743 shares Expires 2032-11-07 F4 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 7, 2022. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:50 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 7,389 | $0.00 Strike: $37.64 | $0.00 |
DisclosureSEC source: 0001127602-22-024916 · form4.xml · derivative · entry 6 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,389 shares Expires 2026-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, December 1, 2016. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:50 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 7,156 | $0.00 Strike: $39.96 | $0.00 |
DisclosureSEC source: 0001127602-22-024916 · form4.xml · derivative · entry 5 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,156 shares Expires 2025-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, November 5, 2015. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:50 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 14,545 | $72.50 | $1,054,512.50 |
DisclosureSEC source: 0001127602-22-024916 · form4.xml · nonDerivative · entry 4 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,811 F4 · kind: Transaction pursuant to an existing 10b5-1 trading plan. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:50 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 7,389 | $37.64 | $278,121.96 |
DisclosureSEC source: 0001127602-22-024916 · form4.xml · nonDerivative · entry 3 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:50 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 7,156 | $39.96 | $285,953.76 |
DisclosureSEC source: 0001127602-22-024916 · form4.xml · nonDerivative · entry 2 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:50 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 20,872 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-024916 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,811 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| March 21, 2022 Filed Mar 21, 2022 20:56 UTC | AMETEK INC/ AME · Entity 3025 | GrantCommon Stock | 1,280 | $134.69 | $172,403.20 |
DisclosureSEC source: 0001127602-22-010038 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,670 F1 · kind: Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:25 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 912 | $72.61 | $66,220.32 |
DisclosureSEC source: 0001127602-21-029120 · form4.xml · nonDerivative · entry 1 Oberton Karleen Marie · CIK 0001314036 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,939 F1 · balance_after: Includes 41,121 restricted stock units/ performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.